Home › Diabete di tipo 2 › Pennsylvania › Philadelphia
Studi clinici su Diabete di tipo 2 a Philadelphia, PA
15 studi su Diabete di tipo 2 cercano partecipanti presso sedi a Philadelphia e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
In reclutamentoFase 2
- Suburban Research Associates, West Chester · a 24 mi di distanza
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
In reclutamentoFase 3
- Thomas Jefferson University, Philadelphia
- Tristar Clinical Investigations PC, Philadelphia
- Suburban Research Associates, West Chester · a 24 mi di distanza
Phenotyping Genetic Risk for Type 2 Diabetes
In reclutamentoVolontari sani benvenuti
- Childrens Hospital of Philadelphia, Philadelphia
- University of Pennsylvania, Philadelphia
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
In reclutamentoFase 3
- AURORA-2 Clinical Site, Philadelphia
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
In reclutamentoFase 2
- Suburban Research Associates, West Chester · a 24 mi di distanza
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
In reclutamentoFase 3
- Research Site, Philadelphia
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
In reclutamentoFase 2
- Suburban Research Associates, West Chester · a 24 mi di distanza
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
In reclutamentoFase 3
- Children's Hosptl Philadelphia, Philadelphia
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
In reclutamentoFase 3
- Children's Hospital of Philadelphia, Philadelphia
- St Christophers Hospital For Children, Philadelphia
The GRoceries Aimed at Increasing Nutrition Study
In reclutamentoIndica un rimborso per i partecipanti
- University of Pennsylvania, Philadelphia
CGM for Management of Type 2 Diabetes in Pregnancy
In reclutamento
- University of Pennsylvania, Philadelphia
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
In reclutamento
- Children's Hospital of Philadelphia, Philadelphia
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
In reclutamentoStudio osservazionale
- Children's Hospital of Philadelphia, Philadelphia
Transformative Research in Diabetic Nephropathy 2.0
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Penn Presbyterian Medical Center, Philadelphia
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
In reclutamento
- Thomas Jefferson University, Philadelphia
Studi su Diabete di tipo 2 in altre città
- San Antonio, TX37 studi
- Houston, TX31 studi
- Orlando, FL24 studi
- Boston, MA20 studi
- Miami, FL19 studi
- Chicago, IL19 studi
- Dallas, TX19 studi
- Columbus, OH18 studi
- Las Vegas, NV18 studi
- Atlanta, GA17 studi
- San Diego, CA17 studi
- Los Angeles, CA16 studi
Altri studi a Philadelphia
- Cancro (tutti i tipi)59 studi
- Cancro al seno56 studi
- Cancro del polmone non a piccole cellule51 studi
- Cancro metastatico46 studi
- Cancro colorettale44 studi
- Cancro ovarico44 studi
- Cancro alla prostata44 studi
- Cancro ai polmoni36 studi
- Leucemia mieloide acuta34 studi
- Insufficienza cardiaca31 studi
- Cancro dell'endometrio28 studi
- Depressione26 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.